U.S. markets closed

NeuroMetrix, Inc. (NURO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
20.97-3.76 (-15.20%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close24.73
Open23.75
Bid20.02 x 1800
Ask20.60 x 800
Day's Range19.10 - 24.47
52 Week Range1.39 - 38.75
Volume14,703,772
Avg. Volume7,224,760
Market Cap118.038M
Beta (5Y Monthly)2.81
PE Ratio (TTM)N/A
EPS (TTM)-0.30
Earnings DateOct 20, 2021 - Oct 25, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMar 28, 2007
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • NeuroMetrix Reports Q2 2021 Financial Results
    GlobeNewswire

    NeuroMetrix Reports Q2 2021 Financial Results

    WOBURN, Mass., July 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2021. The Company is a leader in proprietary non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. Highlights: Revenue of $2.2 million improved 63% from $1.4 million in Q2 2020. The Q2 2020 results were adversely affected by a pandemic-related decline in customer orders. Gross margin on revenue

  • Companies Like NeuroMetrix (NASDAQ:NURO) Can Afford To Invest In Growth
    Simply Wall St.

    Companies Like NeuroMetrix (NASDAQ:NURO) Can Afford To Invest In Growth

    Just because a business does not make any money, does not mean that the stock will go down. Indeed, NeuroMetrix...

  • TheStreet.com

    Premarket Movers Wednesday: Chembio, NeuroMetrix, Johnson & Johnson

    Stocks moving in premarket trading Wednesday include Chembio, NeuroMetrix, Johnson & Johnson, Coke and Verizon.